OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Treatment of Multiple Myeloma

home / peer-exchange / treatment-of-multiple-myeloma
Introduction: Redefining Symptomatic Multiple Myeloma

EP. 1: Introduction: Redefining Symptomatic Multiple Myeloma

January 12th 2015
Gene Expression Profiling in Multiple Myeloma

EP. 2: Gene Expression Profiling in Multiple Myeloma

January 12th 2015
Multiple Myeloma Treatment Regimens

EP. 3: Multiple Myeloma Treatment Regimens

January 12th 2015
Transplant and Maintenance Therapy in Multiple Myeloma

EP. 4: Transplant and Maintenance Therapy in Multiple Myeloma

January 12th 2015
Treatment of Elderly Patients With Multiple Myeloma

EP. 5: Treatment of Elderly Patients With Multiple Myeloma

January 12th 2015
Carfilzomib Combination in Relapsed Multiple Myeloma

EP. 6: Carfilzomib Combination in Relapsed Multiple Myeloma

January 12th 2015
Pomalidomide and HDAC Inhibitors in Multiple Myeloma

EP. 7: Pomalidomide and HDAC Inhibitors in Multiple Myeloma

January 12th 2015
Ixazomib and Elotuzumab in Multiple Myeloma

EP. 8: Ixazomib and Elotuzumab in Multiple Myeloma

January 12th 2015
Monoclonal Antibodies in Multiple Myeloma

EP. 9: Monoclonal Antibodies in Multiple Myeloma

January 12th 2015

Latest Conference Coverage

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact